Market Outlook
The global Neurorehabilitation Devices market size was valued at USD 1383.3 million in 2022 and is forecast to a readjusted size of USD 3050.9 million by 2029 with a CAGR of 12.0% during review period.
Neurorehabilitation devices helps to improve function, reduce symptoms and improve the wellbeing of people with diseases such as trauma or disorders of the nervous system. Infections, tumors, disorders, degenerative diseases, injuries and structural defects in the circulatory system can impair the nervous system.
North America is the largest consumption place for Neurorehabilitation devices, with a consumption market share over 40%, followed by Europe. Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%. The classification of Neurorehabilitation devices includes Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, etc. They have been widely used in hospitals and clinics.
This report is a detailed and comprehensive analysis for global Neurorehabilitation Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurorehabilitation Devices market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation Devices market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation Devices market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurorehabilitation Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurorehabilitation Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma AG
Neuronetics
Yiruide
Magstim
VISHEE
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical
Segmentation By Type
Implantable Neurorehabilitation System
Neurorobotic System
Brain Computer Interface
Non-invasive Stimulators
Other
Segmentation By Application
Hospitals
Clinics
Other
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Neurorehabilitation Devices Market in 2025?
The market benefits from rapid advancements in technology, such as AI and robotics, which enhance the effectiveness of neurorehabilitation. Increasing demand for effective therapies for neurological disorders like stroke, Parkinson’s, and spinal cord injuries further strengthens market growth. Also, growing healthcare investments and rising awareness about neurorehabilitation foster expansion.
What are the weaknesses of the Neurorehabilitation Devices Market in 2025?
High costs of advanced neurorehabilitation devices could limit access, particularly in developing regions. The complexity of device use and a lack of trained professionals for proper implementation may hinder market penetration. Additionally, regulatory challenges and long approval timelines for new devices may slow down market growth.
What opportunities exist for the Neurorehabilitation Devices Market in 2025?
With an aging global population, there is an increasing need for neurorehabilitation, providing significant growth potential. Opportunities also lie in expanding to emerging markets, where healthcare infrastructure is improving. Furthermore, advancements in telemedicine and remote monitoring offer new avenues for device integration in rehabilitation programs.
What threats could impact the Neurorehabilitation Devices Market in 2025?
Economic downturns or government budget cuts could affect funding for healthcare systems, which would reduce investments in rehabilitation technologies. Additionally, the emergence of competing therapeutic approaches, such as pharmaceuticals or stem cell therapies, could pose a challenge to the dominance of neurorehabilitation devices.
Market PESTEL Analysis
What political factors could affect the Neurorehabilitation Devices Market in 2025?
Government regulations, policies, and healthcare reforms will play a key role in shaping the market. National health policies focusing on neurological disorder treatment and reimbursement frameworks will influence device adoption. Political instability or changes in healthcare funding could affect investment and availability in different regions.
How could economic factors influence the Neurorehabilitation Devices Market in 2025?
Economic conditions directly impact healthcare budgets and spending. In countries facing financial challenges, there may be reduced healthcare expenditure, limiting access to neurorehabilitation devices. On the other hand, economic growth in developing regions could create new opportunities for market expansion as healthcare infrastructure improves.
What social factors could shape the Neurorehabilitation Devices Market in 2025?
The increasing prevalence of neurological disorders due to an aging population will drive demand for neurorehabilitation devices. Growing awareness of the benefits of early rehabilitation and better outcomes is also influencing societal attitudes, encouraging greater acceptance and adoption of these technologies. Social attitudes towards disability and recovery will also shape market trends.
What technological advancements will impact the Neurorehabilitation Devices Market in 2025?
The integration of AI, robotics, and sensor technologies into neurorehabilitation devices is revolutionizing the market. Innovations in wearable devices, virtual reality, and telemedicine platforms are expected to make rehabilitation more personalized, accessible, and effective. Continuous advancements in data analytics will also enable better monitoring of patient progress.
What environmental factors could influence the Neurorehabilitation Devices Market in 2025?
Environmental sustainability and eco-friendly production processes are becoming increasingly important. Regulations around electronic waste, sustainable materials, and energy-efficient devices will likely impact production and design. However, the environmental impact of these devices is relatively low compared to other medical technologies.
What legal factors should be considered for the Neurorehabilitation Devices Market in 2025?
Regulatory requirements for medical devices, including safety standards, quality control, and intellectual property laws, are critical to the market's development. The approval process for new neurorehabilitation devices must meet stringent legal requirements. Any changes in these regulations could either accelerate or delay market entry for new products.
Market SIPOC Analysis
Who are the suppliers in the Neurorehabilitation Devices Market in 2025?
Suppliers in this market include manufacturers of medical components, software developers, robotics technology firms, and providers of raw materials like sensors, motors, and electronics. These suppliers play a critical role in providing the necessary components for device production and innovation.
Who are the inputs required for the Neurorehabilitation Devices Market in 2025?
The key inputs for this market include advanced technologies such as artificial intelligence, robotics, sensors, and software. Additionally, skilled labor for device design and manufacturing, regulatory approvals, and funding for research and development are also crucial inputs.
What processes are involved in the Neurorehabilitation Devices Market in 2025?
The processes involve the research and development of new neurorehabilitation devices, clinical trials, obtaining regulatory approvals, manufacturing, and distribution. Aftermarket support, such as training for healthcare professionals and ongoing maintenance, also plays a key role.
Who are the customers in the Neurorehabilitation Devices Market in 2025?
Customers include hospitals, rehabilitation centers, outpatient clinics, and long-term care facilities. Additionally, individual patients recovering from neurological conditions, as well as healthcare professionals who administer the devices, are also key customers.
What are the outputs of the Neurorehabilitation Devices Market in 2025?
The primary outputs are neurorehabilitation devices designed to improve recovery for patients with neurological conditions. These devices include robotic exoskeletons, virtual reality-based therapies, and wearable rehabilitation tools. Additionally, data insights and patient progress reports from these devices serve as valuable outputs for healthcare providers.
Market Porter's Five Forces
How strong is the threat of new entrants in the Neurorehabilitation Devices Market in 2025?
The threat of new entrants is moderate. While the market is growing, the high capital investment required for research and development, regulatory approvals, and production can be a significant barrier. Additionally, established players have the advantage of brand recognition and distribution networks, making it challenging for new companies to gain market share.
How intense is the rivalry among existing competitors in the Neurorehabilitation Devices Market in 2025?
Rivalry is high due to the growing demand for advanced neurorehabilitation solutions and the increasing number of players in the market. Companies are competing on innovation, product effectiveness, pricing, and customer service. As the market evolves, companies that fail to stay ahead with technological advancements may lose ground to competitors.
What is the bargaining power of suppliers in the Neurorehabilitation Devices Market in 2025?
The bargaining power of suppliers is moderate. While key components like sensors and robotics come from a small number of specialized suppliers, there are alternative sources for these materials. However, suppliers of highly specialized technology, such as AI and machine learning software, could exert higher bargaining power due to the limited availability of advanced solutions.
What is the bargaining power of buyers in the Neurorehabilitation Devices Market in 2025?
The bargaining power of buyers is moderate. Healthcare providers and institutions often have the purchasing power to negotiate prices, especially when buying in bulk. However, the specialized nature of neurorehabilitation devices means that patients may have limited options, reducing their bargaining power. The increasing demand for effective rehabilitation tools could further shift power toward buyers.
How strong is the threat of substitute products or services in the Neurorehabilitation Devices Market in 2025?
The threat of substitutes is moderate. While there are alternative treatments such as traditional physical therapy, pharmaceuticals, or emerging stem cell therapies, neurorehabilitation devices offer more targeted, precise, and often faster recovery for patients. However, as new therapeutic technologies evolve, substitutes could emerge that challenge the market’s position.
Market Upstream Analysis
What are the key raw materials required for the Neurorehabilitation Devices Market in 2025?
The key raw materials include advanced electronics, sensors, motors, and actuators, which are essential for creating the mechanical and robotic components of rehabilitation devices. Additionally, materials for durable casing, flexible electronics for wearables, and components for virtual reality setups are critical.
Who are the primary suppliers to the Neurorehabilitation Devices Market in 2025?
Primary suppliers include manufacturers of high-tech components such as microprocessors, AI software providers, robotics firms, and sensor manufacturers. Suppliers of durable and lightweight materials for device casings and specialized materials for wearable devices also play a critical role in the supply chain.
What technological developments are impacting the upstream factors in the Neurorehabilitation Devices Market in 2025?
Technological advancements in robotics, AI, machine learning, and sensor technology are transforming the upstream factors. Continuous innovation in these fields is driving the development of more efficient, effective, and precise neurorehabilitation devices. The growing use of cloud computing and big data analytics also supports the development of smart, interconnected devices.
How do regulatory factors affect upstream activities in the Neurorehabilitation Devices Market in 2025?
Regulatory factors significantly influence upstream activities by requiring suppliers to meet stringent quality standards for medical devices. These regulations impact the development, approval, and certification of both raw materials and finished products. Additionally, any changes in international standards or compliance requirements can influence the supply chain, causing delays or increased costs.
What challenges do upstream suppliers face in the Neurorehabilitation Devices Market in 2025?
Upstream suppliers face challenges such as the high cost of research and development to create advanced components, the need to meet complex regulatory standards, and the demand for continuous innovation. Additionally, ensuring the quality and reliability of components, especially for medical applications, is a significant challenge in the upstream process.
Market Midstream Analysis
What are the key processes involved in the midstream of the Neurorehabilitation Devices Market in 2025?
The key processes in the midstream include device assembly, quality control, testing, and integration of technological components such as robotics, AI, and sensors. Manufacturers also focus on research and development to enhance device efficacy, as well as collaboration with healthcare providers to tailor devices for specific patient needs.
How do manufacturers contribute to the Neurorehabilitation Devices Market in 2025?
Manufacturers play a central role in developing and assembling neurorehabilitation devices. They are responsible for integrating advanced technologies, ensuring compliance with regulatory standards, and maintaining high production standards. Manufacturers also engage in continuous innovation to improve device functionality, user experience, and overall treatment outcomes.
What are the challenges faced by manufacturers in the midstream of the Neurorehabilitation Devices Market in 2025?
Manufacturers face challenges related to maintaining the high cost of research and development, long regulatory approval processes, and the need to continually innovate to stay competitive. There is also the complexity of integrating various technological components into a cohesive, user-friendly product that meets the needs of patients and healthcare professionals.
What role does distribution play in the midstream of the Neurorehabilitation Devices Market in 2025?
Distribution is crucial for getting neurorehabilitation devices to hospitals, rehabilitation centers, and clinics. Efficient distribution channels ensure that devices reach the appropriate healthcare providers. Manufacturers often collaborate with distributors and medical supply companies to enhance accessibility and ensure timely delivery to end-users.
How does collaboration with healthcare providers impact the midstream in the Neurorehabilitation Devices Market in 2025?
Collaboration with healthcare providers is essential in the midstream to understand patient needs and ensure that devices are designed and adapted for specific rehabilitation purposes. These collaborations help improve device effectiveness, lead to clinical validations, and ensure that products meet the practical requirements of healthcare professionals working with neurological patients.
Market Downstream Analysis
What are the key activities in the downstream of the Neurorehabilitation Devices Market in 2025?
The key activities in the downstream include device deployment, training healthcare professionals, patient rehabilitation, and after-sales support. Healthcare providers are responsible for integrating the devices into treatment plans, monitoring patient progress, and ensuring the devices are used effectively in real-world settings.
How do healthcare providers influence the downstream of the Neurorehabilitation Devices Market in 2025?
Healthcare providers directly influence the downstream by adopting and utilizing neurorehabilitation devices in their practice. They ensure the devices are properly integrated into patient care, and their feedback is crucial for product improvement. Additionally, their adoption drives market demand and shapes device functionality based on patient outcomes.
What role does patient adoption play in the downstream of the Neurorehabilitation Devices Market in 2025?
Patient adoption plays a significant role in the downstream, as patients are the end-users of the devices. Their willingness to use and engage with these devices for rehabilitation directly impacts market success. Positive patient outcomes and experiences will encourage wider adoption and acceptance of neurorehabilitation technologies.
What are the challenges in the downstream of the Neurorehabilitation Devices Market in 2025?
Challenges in the downstream include the need for specialized training for healthcare professionals to effectively use these advanced devices. Additionally, there may be patient reluctance or difficulties in adapting to new technologies, especially older patients. Access to devices in less developed regions or healthcare systems with limited funding also presents a barrier.
How does customer support influence the downstream in the Neurorehabilitation Devices Market in 2025?
Customer support is vital in the downstream as it ensures the ongoing effectiveness of the devices. Offering maintenance services, troubleshooting, and user guidance helps ensure devices continue to function optimally and that healthcare providers and patients receive the support needed for long-term success. This support fosters trust and loyalty among customers.
Chapter 1, to describe Neurorehabilitation Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurorehabilitation Devices, with revenue, gross margin and global market share of Neurorehabilitation Devices from 2018 to 2023.
Chapter 3, the Neurorehabilitation Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neurorehabilitation Devices market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurorehabilitation Devices.
Chapter 13, to describe Neurorehabilitation Devices research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Neurorehabilitation Devices
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurorehabilitation Devices by Type
1.3.1 Overview: Global Neurorehabilitation Devices Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neurorehabilitation Devices Consumption Value Market Share by Type in 2022
1.3.3 Implantable Neurorehabilitation System
1.3.4 Neurorobotic System
1.3.5 Brain Computer Interface
1.3.6 Non-invasive Stimulators
1.3.7 Other
1.4 Global Neurorehabilitation Devices Market by Application
1.4.1 Overview: Global Neurorehabilitation Devices Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Other
1.5 Global Neurorehabilitation Devices Market Size & Forecast
1.6 Global Neurorehabilitation Devices Market Size and Forecast by Region
1.6.1 Global Neurorehabilitation Devices Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neurorehabilitation Devices Market Size by Region, (2018-2029)
1.6.3 North America Neurorehabilitation Devices Market Size and Prospect (2018-2029)
1.6.4 Europe Neurorehabilitation Devices Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neurorehabilitation Devices Market Size and Prospect (2018-2029)
1.6.6 South America Neurorehabilitation Devices Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neurorehabilitation Devices Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neurorehabilitation Devices Product and Solutions
2.1.4 Medtronic Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Neurorehabilitation Devices Product and Solutions
2.2.4 Abbott Laboratories Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Neurorehabilitation Devices Product and Solutions
2.3.4 Boston Scientific Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boston Scientific Recent Developments and Future Plans
2.4 Bioness
2.4.1 Bioness Details
2.4.2 Bioness Major Business
2.4.3 Bioness Neurorehabilitation Devices Product and Solutions
2.4.4 Bioness Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bioness Recent Developments and Future Plans
2.5 Hocoma AG
2.5.1 Hocoma AG Details
2.5.2 Hocoma AG Major Business
2.5.3 Hocoma AG Neurorehabilitation Devices Product and Solutions
2.5.4 Hocoma AG Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hocoma AG Recent Developments and Future Plans
2.6 Neuronetics
2.6.1 Neuronetics Details
2.6.2 Neuronetics Major Business
2.6.3 Neuronetics Neurorehabilitation Devices Product and Solutions
2.6.4 Neuronetics Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Neuronetics Recent Developments and Future Plans
2.7 Yiruide
2.7.1 Yiruide Details
2.7.2 Yiruide Major Business
2.7.3 Yiruide Neurorehabilitation Devices Product and Solutions
2.7.4 Yiruide Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Yiruide Recent Developments and Future Plans
2.8 Magstim
2.8.1 Magstim Details
2.8.2 Magstim Major Business
2.8.3 Magstim Neurorehabilitation Devices Product and Solutions
2.8.4 Magstim Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Magstim Recent Developments and Future Plans
2.9 VISHEE
2.9.1 VISHEE Details
2.9.2 VISHEE Major Business
2.9.3 VISHEE Neurorehabilitation Devices Product and Solutions
2.9.4 VISHEE Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 VISHEE Recent Developments and Future Plans
2.10 Ekso Bionics
2.10.1 Ekso Bionics Details
2.10.2 Ekso Bionics Major Business
2.10.3 Ekso Bionics Neurorehabilitation Devices Product and Solutions
2.10.4 Ekso Bionics Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ekso Bionics Recent Developments and Future Plans
2.11 Alter G
2.11.1 Alter G Details
2.11.2 Alter G Major Business
2.11.3 Alter G Neurorehabilitation Devices Product and Solutions
2.11.4 Alter G Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Alter G Recent Developments and Future Plans
2.12 MagVenture
2.12.1 MagVenture Details
2.12.2 MagVenture Major Business
2.12.3 MagVenture Neurorehabilitation Devices Product and Solutions
2.12.4 MagVenture Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 MagVenture Recent Developments and Future Plans
2.13 Tyromotion
2.13.1 Tyromotion Details
2.13.2 Tyromotion Major Business
2.13.3 Tyromotion Neurorehabilitation Devices Product and Solutions
2.13.4 Tyromotion Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Tyromotion Recent Developments and Future Plans
2.14 Soterix Medical
2.14.1 Soterix Medical Details
2.14.2 Soterix Medical Major Business
2.14.3 Soterix Medical Neurorehabilitation Devices Product and Solutions
2.14.4 Soterix Medical Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Soterix Medical Recent Developments and Future Plans
2.15 Neuroelectrics
2.15.1 Neuroelectrics Details
2.15.2 Neuroelectrics Major Business
2.15.3 Neuroelectrics Neurorehabilitation Devices Product and Solutions
2.15.4 Neuroelectrics Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Neuroelectrics Recent Developments and Future Plans
2.16 Bionik Laboratories
2.16.1 Bionik Laboratories Details
2.16.2 Bionik Laboratories Major Business
2.16.3 Bionik Laboratories Neurorehabilitation Devices Product and Solutions
2.16.4 Bionik Laboratories Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Bionik Laboratories Recent Developments and Future Plans
2.17 Helius Medical
2.17.1 Helius Medical Details
2.17.2 Helius Medical Major Business
2.17.3 Helius Medical Neurorehabilitation Devices Product and Solutions
2.17.4 Helius Medical Neurorehabilitation Devices Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Helius Medical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neurorehabilitation Devices Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neurorehabilitation Devices by Company Revenue
3.2.2 Top 3 Neurorehabilitation Devices Players Market Share in 2022
3.2.3 Top 6 Neurorehabilitation Devices Players Market Share in 2022
3.3 Neurorehabilitation Devices Market: Overall Company Footprint Analysis
3.3.1 Neurorehabilitation Devices Market: Region Footprint
3.3.2 Neurorehabilitation Devices Market: Company Product Type Footprint
3.3.3 Neurorehabilitation Devices Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Neurorehabilitation Devices Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neurorehabilitation Devices Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Neurorehabilitation Devices Consumption Value Market Share by Application (2018-2023)
5.2 Global Neurorehabilitation Devices Market Forecast by Application (2024-2029)
6 North America
6.1 North America Neurorehabilitation Devices Consumption Value by Type (2018-2029)
6.2 North America Neurorehabilitation Devices Consumption Value by Application (2018-2029)
6.3 North America Neurorehabilitation Devices Market Size by Country
6.3.1 North America Neurorehabilitation Devices Consumption Value by Country (2018-2029)
6.3.2 United States Neurorehabilitation Devices Market Size and Forecast (2018-2029)
6.3.3 Canada Neurorehabilitation Devices Market Size and Forecast (2018-2029)
6.3.4 Mexico Neurorehabilitation Devices Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Neurorehabilitation Devices Consumption Value by Type (2018-2029)
7.2 Europe Neurorehabilitation Devices Consumption Value by Application (2018-2029)
7.3 Europe Neurorehabilitation Devices Market Size by Country
7.3.1 Europe Neurorehabilitation Devices Consumption Value by Country (2018-2029)
7.3.2 Germany Neurorehabilitation Devices Market Size and Forecast (2018-2029)
7.3.3 France Neurorehabilitation Devices Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neurorehabilitation Devices Market Size and Forecast (2018-2029)
7.3.5 Russia Neurorehabilitation Devices Market Size and Forecast (2018-2029)
7.3.6 Italy Neurorehabilitation Devices Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation Devices Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neurorehabilitation Devices Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neurorehabilitation Devices Market Size by Region
8.3.1 Asia-Pacific Neurorehabilitation Devices Consumption Value by Region (2018-2029)
8.3.2 China Neurorehabilitation Devices Market Size and Forecast (2018-2029)
8.3.3 Japan Neurorehabilitation Devices Market Size and Forecast (2018-2029)
8.3.4 South Korea Neurorehabilitation Devices Market Size and Forecast (2018-2029)
8.3.5 India Neurorehabilitation Devices Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neurorehabilitation Devices Market Size and Forecast (2018-2029)
8.3.7 Australia Neurorehabilitation Devices Market Size and Forecast (2018-2029)
9 South America
9.1 South America Neurorehabilitation Devices Consumption Value by Type (2018-2029)
9.2 South America Neurorehabilitation Devices Consumption Value by Application (2018-2029)
9.3 South America Neurorehabilitation Devices Market Size by Country
9.3.1 South America Neurorehabilitation Devices Consumption Value by Country (2018-2029)
9.3.2 Brazil Neurorehabilitation Devices Market Size and Forecast (2018-2029)
9.3.3 Argentina Neurorehabilitation Devices Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation Devices Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neurorehabilitation Devices Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neurorehabilitation Devices Market Size by Country
10.3.1 Middle East & Africa Neurorehabilitation Devices Consumption Value by Country (2018-2029)
10.3.2 Turkey Neurorehabilitation Devices Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neurorehabilitation Devices Market Size and Forecast (2018-2029)
10.3.4 UAE Neurorehabilitation Devices Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Neurorehabilitation Devices Market Drivers
11.2 Neurorehabilitation Devices Market Restraints
11.3 Neurorehabilitation Devices Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Neurorehabilitation Devices Industry Chain
12.2 Neurorehabilitation Devices Upstream Analysis
12.3 Neurorehabilitation Devices Midstream Analysis
12.4 Neurorehabilitation Devices Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Neurorehabilitation Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurorehabilitation Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Neurorehabilitation Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Neurorehabilitation Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Medtronic Company Information, Head Office, and Major Competitors
Table 6. Medtronic Major Business
Table 7. Medtronic Neurorehabilitation Devices Product and Solutions
Table 8. Medtronic Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Medtronic Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Neurorehabilitation Devices Product and Solutions
Table 13. Abbott Laboratories Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Boston Scientific Company Information, Head Office, and Major Competitors
Table 16. Boston Scientific Major Business
Table 17. Boston Scientific Neurorehabilitation Devices Product and Solutions
Table 18. Boston Scientific Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Boston Scientific Recent Developments and Future Plans
Table 20. Bioness Company Information, Head Office, and Major Competitors
Table 21. Bioness Major Business
Table 22. Bioness Neurorehabilitation Devices Product and Solutions
Table 23. Bioness Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bioness Recent Developments and Future Plans
Table 25. Hocoma AG Company Information, Head Office, and Major Competitors
Table 26. Hocoma AG Major Business
Table 27. Hocoma AG Neurorehabilitation Devices Product and Solutions
Table 28. Hocoma AG Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hocoma AG Recent Developments and Future Plans
Table 30. Neuronetics Company Information, Head Office, and Major Competitors
Table 31. Neuronetics Major Business
Table 32. Neuronetics Neurorehabilitation Devices Product and Solutions
Table 33. Neuronetics Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Neuronetics Recent Developments and Future Plans
Table 35. Yiruide Company Information, Head Office, and Major Competitors
Table 36. Yiruide Major Business
Table 37. Yiruide Neurorehabilitation Devices Product and Solutions
Table 38. Yiruide Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Yiruide Recent Developments and Future Plans
Table 40. Magstim Company Information, Head Office, and Major Competitors
Table 41. Magstim Major Business
Table 42. Magstim Neurorehabilitation Devices Product and Solutions
Table 43. Magstim Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Magstim Recent Developments and Future Plans
Table 45. VISHEE Company Information, Head Office, and Major Competitors
Table 46. VISHEE Major Business
Table 47. VISHEE Neurorehabilitation Devices Product and Solutions
Table 48. VISHEE Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. VISHEE Recent Developments and Future Plans
Table 50. Ekso Bionics Company Information, Head Office, and Major Competitors
Table 51. Ekso Bionics Major Business
Table 52. Ekso Bionics Neurorehabilitation Devices Product and Solutions
Table 53. Ekso Bionics Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Ekso Bionics Recent Developments and Future Plans
Table 55. Alter G Company Information, Head Office, and Major Competitors
Table 56. Alter G Major Business
Table 57. Alter G Neurorehabilitation Devices Product and Solutions
Table 58. Alter G Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Alter G Recent Developments and Future Plans
Table 60. MagVenture Company Information, Head Office, and Major Competitors
Table 61. MagVenture Major Business
Table 62. MagVenture Neurorehabilitation Devices Product and Solutions
Table 63. MagVenture Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. MagVenture Recent Developments and Future Plans
Table 65. Tyromotion Company Information, Head Office, and Major Competitors
Table 66. Tyromotion Major Business
Table 67. Tyromotion Neurorehabilitation Devices Product and Solutions
Table 68. Tyromotion Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Tyromotion Recent Developments and Future Plans
Table 70. Soterix Medical Company Information, Head Office, and Major Competitors
Table 71. Soterix Medical Major Business
Table 72. Soterix Medical Neurorehabilitation Devices Product and Solutions
Table 73. Soterix Medical Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Soterix Medical Recent Developments and Future Plans
Table 75. Neuroelectrics Company Information, Head Office, and Major Competitors
Table 76. Neuroelectrics Major Business
Table 77. Neuroelectrics Neurorehabilitation Devices Product and Solutions
Table 78. Neuroelectrics Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Neuroelectrics Recent Developments and Future Plans
Table 80. Bionik Laboratories Company Information, Head Office, and Major Competitors
Table 81. Bionik Laboratories Major Business
Table 82. Bionik Laboratories Neurorehabilitation Devices Product and Solutions
Table 83. Bionik Laboratories Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Bionik Laboratories Recent Developments and Future Plans
Table 85. Helius Medical Company Information, Head Office, and Major Competitors
Table 86. Helius Medical Major Business
Table 87. Helius Medical Neurorehabilitation Devices Product and Solutions
Table 88. Helius Medical Neurorehabilitation Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Helius Medical Recent Developments and Future Plans
Table 90. Global Neurorehabilitation Devices Revenue (USD Million) by Players (2018-2023)
Table 91. Global Neurorehabilitation Devices Revenue Share by Players (2018-2023)
Table 92. Breakdown of Neurorehabilitation Devices by Company Type (Tier 1, Tier 2, and Tier 3)
Table 93. Market Position of Players in Neurorehabilitation Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 94. Head Office of Key Neurorehabilitation Devices Players
Table 95. Neurorehabilitation Devices Market: Company Product Type Footprint
Table 96. Neurorehabilitation Devices Market: Company Product Application Footprint
Table 97. Neurorehabilitation Devices New Market Entrants and Barriers to Market Entry
Table 98. Neurorehabilitation Devices Mergers, Acquisition, Agreements, and Collaborations
Table 99. Global Neurorehabilitation Devices Consumption Value (USD Million) by Type (2018-2023)
Table 100. Global Neurorehabilitation Devices Consumption Value Share by Type (2018-2023)
Table 101. Global Neurorehabilitation Devices Consumption Value Forecast by Type (2024-2029)
Table 102. Global Neurorehabilitation Devices Consumption Value by Application (2018-2023)
Table 103. Global Neurorehabilitation Devices Consumption Value Forecast by Application (2024-2029)
Table 104. North America Neurorehabilitation Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 105. North America Neurorehabilitation Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 106. North America Neurorehabilitation Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 107. North America Neurorehabilitation Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 108. North America Neurorehabilitation Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 109. North America Neurorehabilitation Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 110. Europe Neurorehabilitation Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Europe Neurorehabilitation Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Europe Neurorehabilitation Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 113. Europe Neurorehabilitation Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 114. Europe Neurorehabilitation Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Neurorehabilitation Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Neurorehabilitation Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 117. Asia-Pacific Neurorehabilitation Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 118. Asia-Pacific Neurorehabilitation Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 119. Asia-Pacific Neurorehabilitation Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 120. Asia-Pacific Neurorehabilitation Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 121. Asia-Pacific Neurorehabilitation Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 122. South America Neurorehabilitation Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 123. South America Neurorehabilitation Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 124. South America Neurorehabilitation Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 125. South America Neurorehabilitation Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 126. South America Neurorehabilitation Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 127. South America Neurorehabilitation Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Middle East & Africa Neurorehabilitation Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 129. Middle East & Africa Neurorehabilitation Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 130. Middle East & Africa Neurorehabilitation Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 131. Middle East & Africa Neurorehabilitation Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 132. Middle East & Africa Neurorehabilitation Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 133. Middle East & Africa Neurorehabilitation Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 134. Neurorehabilitation Devices Raw Material
Table 135. Key Suppliers of Neurorehabilitation Devices Raw Materials
List of Figures
Figure 1. Neurorehabilitation Devices Picture
Figure 2. Global Neurorehabilitation Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurorehabilitation Devices Consumption Value Market Share by Type in 2022
Figure 4. Implantable Neurorehabilitation System
Figure 5. Neurorobotic System
Figure 6. Brain Computer Interface
Figure 7. Non-invasive Stimulators
Figure 8. Other
Figure 9. Global Neurorehabilitation Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Neurorehabilitation Devices Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Neurorehabilitation Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Neurorehabilitation Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Neurorehabilitation Devices Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Neurorehabilitation Devices Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Neurorehabilitation Devices Consumption Value Market Share by Region in 2022
Figure 19. North America Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Neurorehabilitation Devices Revenue Share by Players in 2022
Figure 25. Neurorehabilitation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Neurorehabilitation Devices Market Share in 2022
Figure 27. Global Top 6 Players Neurorehabilitation Devices Market Share in 2022
Figure 28. Global Neurorehabilitation Devices Consumption Value Share by Type (2018-2023)
Figure 29. Global Neurorehabilitation Devices Market Share Forecast by Type (2024-2029)
Figure 30. Global Neurorehabilitation Devices Consumption Value Share by Application (2018-2023)
Figure 31. Global Neurorehabilitation Devices Market Share Forecast by Application (2024-2029)
Figure 32. North America Neurorehabilitation Devices Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Neurorehabilitation Devices Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Neurorehabilitation Devices Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Neurorehabilitation Devices Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Neurorehabilitation Devices Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Neurorehabilitation Devices Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 42. France Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Neurorehabilitation Devices Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Neurorehabilitation Devices Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Neurorehabilitation Devices Consumption Value Market Share by Region (2018-2029)
Figure 49. China Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 52. India Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Neurorehabilitation Devices Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Neurorehabilitation Devices Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Neurorehabilitation Devices Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Neurorehabilitation Devices Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Neurorehabilitation Devices Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Neurorehabilitation Devices Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Neurorehabilitation Devices Consumption Value (2018-2029) & (USD Million)
Figure 66. Neurorehabilitation Devices Market Drivers
Figure 67. Neurorehabilitation Devices Market Restraints
Figure 68. Neurorehabilitation Devices Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neurorehabilitation Devices in 2022
Figure 71. Manufacturing Process Analysis of Neurorehabilitation Devices
Figure 72. Neurorehabilitation Devices Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source